Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0001209191-19-057694

Options or other derivatives

  • Chief Scientific Officer acquired 280,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ettenberg Seth Chief Scientific Officer 2019-11-19 Grant or award · Stock Option (Right to Buy) +280,000 280,000 D
Loading xslF345X03/doc4.xml…